July 1st, 2010
Podcast 94: What does a new meta-analysis tell us about statins and primary prevention?
Podcast: Play in new window | Download
Subscribe: RSS
A meta-analysis of 11 studies encompassing more than 60,000 subjects finds that statins don’t lower all-cause mortality in people without cardiovascular disease. One editorialist calls the study, just published in the Archives of Internal Medicine, “the cleanest and most complete meta-analysis of pharmacological lipid lowering for primary prevention.”
One of the study’s principal authors, Kausik K. Ray, talked with us from London. I think you’ll find that listening in is worth your time.
Interview-related links:
News-related links:
- Starting dialysis early doesn’t improve mortality
- Digoxin’s dangers in dialysis
- Rosiglitazone’s bad week
- Tight glucose control in diabetes brings some benefits, but at the cost of “imprudent” risks
- PSA testing for prostate cancer lowers mortality, but mostly in low-screening regions
Categories: Audio, Cardiovascular risk, statins, Uncategorized
Tags: Cardiovascular risk, chronic kidney disease, diabetes, digoxin, hemodialysis, hemoglobin A1c, Jupiter study, Kausik K. Ray, meta-analysis, prevention, prostate screening, PSA, rosiglitazone, statins
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.
About the Podcast
Comments, suggestions, and story ideas welcome. Learn more about Clinical Conversations.
Follow us:
Most Commented
- Podcast 256 — Anthony Fauci: Talking with patients about COVID-19 (27)
- Podcast 266: Interferon and early treatment in COVID-19 bring good outcomes (8)
- Podcast 251: Intermittent fasting (7)
- Podcast 214: Drug-drug interactions and bleeding risks with NOACs (6)
- Podcast 261: COVID-19 as a medical disaster (6)
Subscribe to Clinical Conversations via Email
-
Tag Cloud
- 2009 H1N1 acute coronary syndromes aspirin asthma blood pressure breast cancer cancer risk cardiovascular disease Cardiovascular risk COPD coronary heart disease dabigatran dementia depression diabetes Diabetes type 2 diet Elderly Emergency medicine epidemiology falls FDA glucose guidelines H1N1 Heart failure hypertension influenza pain Patient care patients pregnancy Prostate cancer prostate screening proton pump inhibitors PSA Quality of care risk Rivaroxaban screening smoking stents stroke vaccination warfarin